Professor
University of the Pacific
Xiaoling Li, Ph.D. is a Professor of Pharmaceutics and Associate Dean of Graduate
Education and Research in Thomas J. Long School of Pharmacy and Health Sciences at
the University of the Pacific. Dr. Li is a Fellow of American Association of
Pharmaceutical Scientists and a Fellow of American Institute for Medical and Biological
Engineering. He received BS in Pharmacy and MS in Nuclear Pharmacy from Shanghai
Medical University in 1982 and 1985, respectively. Under the guidance of Dr. Sung Wan
Kim, Dr. Li obtained his Ph.D. in Pharmaceutics from the University of Utah in 1991.
Prior to his academic career, he was a postdoctoral research fellow at Ciba-Geigy Corp
(now Novartis). Dr. Li’s research interest areas include oral mucosal drug delivery, novel
polymers for pharmaceutical and medical application, targeting drug delivery, antibody
mimics, drug transport across biological membranes, and application of physicochemical
concepts to novel dosage form design. His research projects are funded by both NIH and
pharmaceutical industry. He holds 10 patents with 41 patent applications pending and
has published 95 papers/book chapters, over 160 abstracts/presentations, and two books
entitled “Design of Controlled Release Drug Delivery Systems” and “Oral
Bioavailability”. Dr. Li received CRS Outstanding Paper Award for the Journal of
Controlled Release in 1992. He is a Thomas J. Long Fellow, recognized as a
Distinguished Faculty Research Lecturer (2003), received Distinguished Faculty Award
(2012) and Eberhardt Teacher/Scholar Award (2019) at the University of the Pacific. Dr.
Li is the recipient of AAPS Outstanding Educator Award in 2015. He is a member of the
Association of American Pharmaceutical Scientists, Controlled Release Society, and a
convention member of USP. Dr. Li has mentored and trained 26 Ph.D., 3 MS, 16 post
doctoral research fellows, and 18 visiting scientists. He co-founded two companies,
Formurex, Inc., a formulation development company in 2006 and Triastek, a 3D printing
pharmaceutical company in 2015. Dr. Li works closely with the pharmaceutical industry
and provides consultation for product development to various pharmaceutical companies.